Adult Coats’ Disease Successfully Managed with the Dexamethasone Intravitreal Implant (Ozurdex®) Combined with Retinal Photocoagulation

PURPOSE: To report a case of Coats’ disease managed with the dexamethasone intravitreal implant Ozurdex(®) (Allergan, Inc., Irvine, Calif., USA) combined with retinal photocoagulation. METHODS: A 46-year-old female with 20/200 visual acuity was diagnosed with Coats’ disease with secondary retinal va...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Castillo, Sebastián, Gallego-Pinazo, Roberto, Dolz-Marco, Rosa, Marín-Lambíes, Cristina, Díaz-Llopis, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2012
Materias:
Published: March, 2012
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339664/
https://www.ncbi.nlm.nih.gov/pubmed/22548046
http://dx.doi.org/10.1159/000337481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339664/
https://www.ncbi.nlm.nih.gov/pubmed/22548046
http://dx.doi.org/10.1159/000337481

Ejemplares similares